发明名称 CYCLOPENTA[D]PYRAZOLO[1,5-A]PYRIMIDINE COMPOUND AS CRF RECEPTOR ANTAGONIST
摘要 <p>Tri- heterocyclic compound of formula (I) &lt;CHEM&gt; wherein each of W, X and Y is carbon or nitrogen; each of U and Z is CR&lt;2&gt;, NR&lt;13&gt;, nitrogen, oxygen, sulfur etc.; A ring is carbocyclic ring, heterocyclic ring; R&lt;1&gt; is alkyl, alkenyl, alkynyl, NR&lt;4&gt;R&lt;5&gt;, OR&lt;6&gt; etc.; R&lt;3&gt; is carbocyclic ring, heterocyclic ring; and a pharmaceutically acceptable salt thereof, a process for the preparation thereof, a pharmaceutical comprising them as an active ingredient. &lt;??&gt;A compound of formula (I) is useful, in order to possess corticotropin releasing factor receptor antagonistic activity, for the prevention and/or treatment of depression, anxiety, eating disorder, posttraumatic stress disorder, peptic ulcer, irritable bowl syndrome, Alzheimer's disease, drug addiction or alcohol dependence syndrome etc.</p>
申请公布号 EP1354884(A1) 申请公布日期 2003.10.22
申请号 EP20010995808 申请日期 2001.12.27
申请人 ONO PHARMACEUTICAL CO., LTD. 发明人 NAKAI, HISAO;KAGAMIISHI, Y.
分类号 A61P1/04;C07D487/04;A61K31/437;A61K31/519;A61P1/00;A61P1/08;A61P1/10;A61P1/12;A61P1/14;A61P3/04;A61P3/08;A61P5/14;A61P9/00;A61P9/02;A61P9/04;A61P9/06;A61P9/10;A61P9/12;A61P11/06;A61P13/02;A61P17/06;A61P19/02;A61P19/10;A61P25/00;A61P25/04;A61P25/06;A61P25/08;A61P25/14;A61P25/16;A61P25/20;A61P25/22;A61P25/24;A61P25/28;A61P25/30;A61P25/32;A61P27/02;A61P29/00;A61P37/08;A61P43/00;C07D471/04;C07D487/14;C07D491/14;C07D491/147;C07D495/14;(IPC1-7):C07D471/04 主分类号 A61P1/04
代理机构 代理人
主权项
地址